Table II.
Clinical outcome data.
| n | Baseline | Follow-up | p | |
|---|---|---|---|---|
| NRS* | ||||
| Non-regression | 4 | 6.0±1.1[6.0(5.0-7.0)] | 4.7±0.9[6.0(5.0-7.0)] | 0.102 |
| Partial Regression | 6 | 6.6±1.2[6.5(5.7-8.0)] | 3,6±2,2[2,5(2.0-6.2)] | 0.063 |
| Complete Resolution | 30 | 6.9±1.7[7.0(5.7-8.0)] | 2.9±2.0[3.0(1.0-4.2)] | <0.001 |
| ODI* | ||||
| Non-regression | 4 | 25.5±7.5[23.0(20.0-33.5)] | 19.2±7.8[22.0(11.0-24.7)] | 0.109 |
| Partial Regression | 6 | 28.6±10.3[29.5(18.7-38.5)] | 14.3±9.9[12.0(6.2-22.7)] | 0.043 |
| Complete Resolution | 30 | 23.3±11.8[20.0(14.0-32.2)] | 12.1±9.3[11.0(4.0-18.5)] | <0.001 |
| Muscle Weakness | 0.281 | |||
| Non-regression | 4 | 0 (0.0%) | 0 (0.0%) | |
| Partial Regression | 6 | 1 (16.7%) | 0 (0.0%) | |
| Complete Resolution | 30 | 5 (16.7%) | 2 (6.7%) | |
NRS: Numeric Rating Scale, ODI: Oswestry Disability Index,
*
Mean±SD [Median (Interquartile Range)].